Pegasus Pharmaceuticals Inc./Heartview Signs Multi-Year Sales Agreement For China For Ground-Breaking HeartVue(TM) 6C System Technology

February 9, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Pegasus/Heartview LLC (OTC: PGUZ) today announced that it has signed a sales agreement to market and distribute its HeartVue™ 6C System in China and southern Asia through the Pegasus PharmGroup and its marketing subsidiary, Pegasus Lifecare Inc.

Twitter
LinkedIn
Facebook
Email
Print

Alliances